Wellness Index Report, an independent wellness ratings and education platform, has recognized Nefense as a leader in nasal health innovation in a new Inside the Index feature. The report highlights the company's hypochlorous acid (HOCl) and xylitol-based nasal solutions as drug-free alternatives to traditional over-the-counter sprays.
The feature examines emerging research on hypochlorous acid, noting its antimicrobial and anti-inflammatory properties, as well as its potential applications in respiratory health and infection control. According to Wellness Index Report, Nefense's products are doctor-recommended, ENT-approved, and family-friendly, formulated under the direction of Dr. Richard Downs, DDS.
Founded by Lindsay O'Neill-O’Keefe, Wellness Index Report aims to help consumers and medical providers identify evidence-informed wellness solutions through expert review, customer feedback, scientific evaluation, and ongoing performance monitoring. The organization's Inside the Index editorial series highlights companies, practitioners, and technologies shaping the future of wellness and longevity.
The recognition of Nefense underscores a broader consumer shift toward drug-free nasal care as individuals seek alternatives to traditional medications for respiratory hygiene. With growing concerns about antimicrobial resistance and side effects from conventional treatments, HOCl-based products offer a promising option for daily nasal maintenance and infection prevention.
Wellness Index Report's analysis points to increased consumer interest in nasal health, driven in part by heightened awareness of respiratory hygiene following recent global health challenges. The report suggests that Nefense's approach aligns with a growing preference for non-pharmaceutical interventions, particularly among families looking for gentle yet effective solutions.
For more details, the full announcement is available at Newsworthy.ai and distributed by Reportable, Inc.
